Related Experiment Video
Updated: May 7, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
Triglyceride Metabolism and Hepatic Diseases
1Universidad Nacional Autónoma de México/Instituto Nacional de Pediatría, Mexico. crisfern@biomedicas.unam.mx.
Mini Reviews in Medicinal Chemistry
|September 17, 2013
Summary
Impaired triglyceride metabolism contributes to liver diseases like fatty liver and fibrosis. Understanding these molecular mechanisms is key for early diagnosis and treatment strategies.
Area of Science:
- Molecular Biology
- Metabolic Diseases
- Hepatology
Background:
- Triglycerides are crucial for energy storage and cellular functions.
- The liver plays a central role in triglyceride metabolism.
- Metabolic syndrome and associated liver diseases are significant global health concerns.
Purpose of the Study:
- To review molecular mechanisms linking impaired triglyceride metabolism to liver diseases.
- To discuss inflammation, insulin resistance, gut microbiota, and oxidative stress in fatty liver disease.
- To explore the progression from fatty liver to cancer.
Main Methods:
- Literature review of molecular actions in triglyceride metabolism and hepatic diseases.
- Discussion of inflammatory pathways, insulin resistance, and gut microbiome influence.
- Analysis of oxidative stress and growth factor roles in disease progression.
Main Results:
- Impaired triglyceride metabolism is linked to hepatic alterations including steatosis, steatohepatitis, fibrosis, and cancer.
- Chronic inflammation, insulin resistance, gut permeability, and oxidative stress are key contributors.
- Fatty acid accumulation drives changes leading to neoplastic cell development.
Conclusions:
- Understanding molecular pathways is vital for developing diagnostic markers for liver diseases.
- Early diagnosis is challenging due to asymptomatic onset.
- Targeting molecular mechanisms could lead to improved therapeutic strategies.
Related Concept Videos
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...